EXTON, Pa., Feb. 7, 2012 /PRNewswire/ -- ViroPharma Incorporated today announced the U.S Food and Drug Administration (FDA) issued a complete response letter regarding Cinryze® (C1 Esterase Inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results